IL5 and eosinophilic esophagitis: More recently, de Oliveira et al.83 performed a systematic meta-analysis to assess the treatment efficacy and safety of monoclonal antibodies specifically targeting IL-4, IL-5, and IL-13 signals in treating EoE.